Interventions to address sexual problems in people with cancer
- PMID: 28680280
- PMCID: PMC5486385
- DOI: 10.3747/co.24.3583
Interventions to address sexual problems in people with cancer
Abstract
Background: Sexual dysfunction in people with cancer is a significant problem. The present clinical practice guideline makes recommendations to improve sexual function in people with cancer.
Methods: This guideline was undertaken by the Interventions to Address Sexual Problems in People with Cancer Expert Panel, a group organized by the Program in Evidence-Based Care (pebc). Consistent with the pebc standardized approach, a systematic search was conducted for existing guidelines, and the literature in medline and embase for the years 2003-2015 was systematically searched for both systematic reviews and primary literature. Evidence found for men and for women was evaluated separately, and no restrictions were placed on cancer type or study design. Content and methodology experts performed an internal review of the resulting draft recommendations, which was followed by an external review by targeted experts and intended users.
Results: The search identified 4 existing guidelines, 13 systematic reviews, and 103 studies with relevance to the topic. The present guideline provides one overarching recommendation concerning the discussion of sexual health and dysfunction, which is aimed at all people with cancer. Eleven additional recommendations made separately for men and women deal with issues such as sexual response, body image, intimacy and relationships, overall sexual functioning and satisfaction, and vasomotor and genital symptoms.
Conclusions: To our knowledge this clinical practice guideline is the first to comprehensively evaluate interventions for the improvement of sexual problems in people with cancer. The guideline will be a valuable resource to support practitioners and clinics in addressing sexuality in cancer survivors.
Keywords: Sexual problems; interventions; practice guidelines.
Conflict of interest statement
We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare the following interests: LB is a member of the writing group for the Scientific Network on Female Sexual Health and Cancer and a cco clinical lead in patient-reported outcomes. DE has been a speaker to the advisory boards for Lilly and Pfizer and a consultant to AMS, Pfizer, Lilly, and Astellas; DE has also received research support from Prostate Cancer Canada and from AMS. AK is employed as sexual counsellor at CancerCare Manitoba. WW has received support from Pfizer for a fellowship and database development and is an author of a sexuality guideline for the Society of Obstetricians and Gynaecologists of Canada. CZ, AM, and KM have no competing interests to declare.
References
-
- Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003;56:937–49. doi: 10.1016/S0360-3016(03)00362-6. [Erratum in: Int J Radiat Oncol Biol Phys 2004;58:1321] - DOI - PubMed
-
- Gilbert A, Ziegler L, Martland M, et al. Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician toxicity reporting. Int J Radiat Oncol Biol Phys. 2015;92:555–67. doi: 10.1016/j.ijrobp.2015.02.021. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
